208 related articles for article (PubMed ID: 36814254)
21. The feasibility, repeatability, validity and responsiveness of the EQ-5D-3L in Krio for patients with stroke in Sierra Leone.
Youkee D; Pessima S; Sackley C; Soley-Bori M; Deen GF; Marshall IJ
Health Qual Life Outcomes; 2024 Mar; 22(1):29. PubMed ID: 38549069
[TBL] [Abstract][Full Text] [Related]
22. Comparative Psychometric Performance of Common Generic Paediatric Health-Related Quality of Life Instrument Descriptive Systems: Results from the Australian Paediatric Multi-Instrument Comparison Study.
Jones R; O'Loughlin R; Xiong X; Bahrampour M; Devlin N; Hiscock H; Chen G; Mulhern B; Dalziel K;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):39-55. PubMed ID: 37955799
[TBL] [Abstract][Full Text] [Related]
23. Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients.
Fitriana TS; Purba FD; Rahmatika R; Muhaimin R; Sari NM; Bonsel G; Stolk E; Busschbach JJV
Health Qual Life Outcomes; 2021 Nov; 19(1):256. PubMed ID: 34781978
[TBL] [Abstract][Full Text] [Related]
24. Measurement Properties of the Online EuroQol-5D-Youth Instrument in Children and Adolescents With Type 1 Diabetes Mellitus: Questionnaire Study.
Mayoral K; Rajmil L; Murillo M; Garin O; Pont A; Alonso J; Bel J; Perez J; Corripio R; Carreras G; Herrero J; Mengibar JM; Rodriguez-Arjona D; Ravens-Sieberer U; Raat H; Serra-Sutton V; Ferrer M
J Med Internet Res; 2019 Nov; 21(11):e14947. PubMed ID: 31714252
[TBL] [Abstract][Full Text] [Related]
25. Psychometric Properties of the EQ-5D-Y-5L for Children With Intellectual Disability.
Downs J; Norman R; Mulhern B; Jacoby P; Reddihough D; Choong CS; Finlay-Jones A; Blackmore AM
Value Health; 2024 Jun; 27(6):776-783. PubMed ID: 38467188
[TBL] [Abstract][Full Text] [Related]
26. Validity and reliability of EQ-5D-3L for breast cancer patients in Korea.
Kim SH; Jo MW; Lee JW; Lee HJ; Kim JK
Health Qual Life Outcomes; 2015 Dec; 13():203. PubMed ID: 26694964
[TBL] [Abstract][Full Text] [Related]
27. Reliability and validity of the EQ-5D-3L for Kashin-Beck disease in China.
Fang H; Farooq U; Wang D; Yu F; Younus MI; Guo X
Springerplus; 2016; 5(1):1924. PubMed ID: 27917330
[TBL] [Abstract][Full Text] [Related]
28. Normative Values and Psychometric Properties of EQ-5D-Y-3L in Chilean Youth Population among Different Weight Statuses.
Perez-Sousa MA; Olivares PR; Carrasco-Zahinos R; Garcia-Hermoso A
Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901107
[TBL] [Abstract][Full Text] [Related]
29. A Qualitative Investigation to Develop an Adapted Version of the EQ-5D-Y-3L for Use in Children Aged 2-4 Years.
Dalziel K; van Heusden A; Sarvananthar J; Jones R; McGregor K; Huang L; Rivero-Arias O; Herdman M; Hiscock H; Devlin N
Value Health; 2023 Oct; 26(10):1525-1534. PubMed ID: 37348834
[TBL] [Abstract][Full Text] [Related]
30. A Comparison of the Psychometric Properties of the EQ-5D-Y-3L and EQ-5D-Y-5L Using Paediatric Multi-Instrument Comparison (P-MIC) Study Data.
Bahrampour M; Devlin N; Jones R; Dalziel K; Mulhern B;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):95-111. PubMed ID: 38748193
[TBL] [Abstract][Full Text] [Related]
31. Psychometric properties of the Japanese version of the EQ-5D-Y by self-report and proxy-report: reliability and construct validity.
Shiroiwa T; Fukuda T; Shimozuma K
Qual Life Res; 2019 Nov; 28(11):3093-3105. PubMed ID: 31243620
[TBL] [Abstract][Full Text] [Related]
32. Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement.
Conner-Spady BL; Marshall DA; Bohm E; Dunbar MJ; Loucks L; Al Khudairy A; Noseworthy TW
Qual Life Res; 2015 Jul; 24(7):1775-84. PubMed ID: 25555837
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the EQ-5D-Y-5L, EQ-5D-Y-3L and PedsQL in children and adolescents.
Verstraete J; Scott D
J Patient Rep Outcomes; 2022 Jun; 6(1):67. PubMed ID: 35708825
[TBL] [Abstract][Full Text] [Related]
34. Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population.
Kangwanrattanakul K; Parmontree P
Qual Life Res; 2020 Dec; 29(12):3407-3417. PubMed ID: 32780315
[TBL] [Abstract][Full Text] [Related]
35. Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population.
Shafie AA; Vasan Thakumar A; Lim CJ; Luo N
Qual Life Res; 2019 Jan; 28(1):153-162. PubMed ID: 30317426
[TBL] [Abstract][Full Text] [Related]
36. Validity and reliability of the EQ-5D-3L (a generic preference-based instrument used for calculating quality-adjusted life -years) for patients with type 2 diabetes in Iran.
Zare F; Ameri H; Madadizadeh F; Aghaei MR
Diabetes Metab Syndr; 2021; 15(1):319-324. PubMed ID: 33486224
[TBL] [Abstract][Full Text] [Related]
37. A head-to-head comparison of measurement properties of the EQ-5D-3L and EQ-5D-5L in acute myeloid leukemia patients.
Yu H; Zeng X; Sui M; Liu R; Tan RL; Yang J; Huang W; Luo N
Qual Life Res; 2021 Mar; 30(3):855-866. PubMed ID: 32965633
[TBL] [Abstract][Full Text] [Related]
38. Construct validity and reliability of EQ-5D-3L for stroke survivors in a lower middle income setting.
Mahesh PKB; Gunathunga MW; Jayasinghe S; Arnold SM; Senanayake S; Senanayake C; De Silva LSD; Kularatna S
Ceylon Med J; 2019 Jun; 64(2):52-58. PubMed ID: 31455067
[TBL] [Abstract][Full Text] [Related]
39. An Investigation of Inter-Rater and Intra-Proxy Agreement in Measuring Quality of Life of Children in the Community Using the EQ-5D-Y-3L.
Khanna D; Khadka J; Mpundu-Kaambwa C; Chen G; Dalziel K; Devlin N; Ratcliffe J;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):113-128. PubMed ID: 38280125
[TBL] [Abstract][Full Text] [Related]
40. Measurement properties of the EQ-5D-Y administered through a smartphone app in children with asthma: a longitudinal questionnaire study.
Mayoral K; Garin O; Lizano-Barrantes C; Pont A; Caballero-Rabasco AM; Praena-Crespo M; Valdesoiro-Navarrete L; Guerra MT; Castillo JA; Mir I; Tato E; Alonso J; Serra-Sutton V; Pardo Y; Ferrer M;
Health Qual Life Outcomes; 2022 Mar; 20(1):51. PubMed ID: 35346225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
